Vivere Peptides is an independent research compound supplier headquartered in Bozeman, Montana. We exist for one reason: to give scientists access to the highest-purity peptides backed by analytical documentation that actually means something. Every lot we ship has been independently verified by two ISO/IEC 17025 accredited laboratories — because a Certificate of Analysis is only as good as the lab that produced it.
The peptide research market has a documentation problem. Too many suppliers treat Certificates of Analysis as marketing collateral rather than analytical evidence. Single-lab testing, vague methodologies, and missing acceptance criteria have become industry norms — and researchers are the ones who pay the price.
We started Vivere Peptides because we believed the market needed a supplier that treated analytical verification as a core product feature, not an afterthought. Our founders come from backgrounds in analytical chemistry, pharmaceutical quality systems, and scientific supply-chain management.
Every compound in our catalog undergoes a 7-point analytical verification protocol executed across two independent ISO/IEC 17025 accredited laboratories. We publish full chromatograms, mass spectra, endotoxin results, and elemental impurity panels — not because regulations require it, but because researchers deserve it.
We are not a compounding pharmacy. We do not make medical claims. We supply research-grade compounds with research-grade documentation to qualified professionals who understand the distinction. That clarity of purpose is the foundation of everything we build.
We will never overstate efficacy, misrepresent regulatory status, or publish unverified claims. Every product page, CoA, and marketing asset is held to the same evidentiary standard we expect from research itself.
We prominently label every compound as Research Use Only and refuse to market products for human or veterinary use. We believe regulatory honesty is a competitive advantage, not a liability.
From raw synthesis to final shipment, every lot is tracked through our QMS. Researchers receive a full analytical dossier — not a single-page summary — with every order.
Same-day fulfillment from our Bozeman facility. Climate-controlled storage. Tamper-evident packaging. We treat logistics as part of the scientific supply chain, not an afterthought.
Our team includes specialists who understand peptide chemistry, HPLC methodology, and reconstitution protocols. When you contact us, you reach someone who speaks your language.
Every compound in our catalog completes this protocol before release. No exceptions. No abbreviated panels. No single-lab shortcuts.
Molecular weight and fragmentation pattern confirmed against reference standard. Every lot must match expected mass ± 0.5 Da.
Reverse-phase HPLC with UV detection at 220 nm. Minimum acceptance criterion: ≥99.0% main peak area. Full chromatogram included in every CoA.
Limulus amebocyte lysate assay per USP <85>. Acceptance limit: <1.0 EU/mg. Critical for any injectable-route research application.
Full heavy-metal screen per ICH Q3D guidelines. Quantitative limits for Cd, Pb, As, Hg, and 20+ additional elements. Results reported in ppm.
Sterility testing at two independent ISO 17025 labs. Bioburden enumeration and specified organism screening. No lot ships without dual-lab concordance.
Both partner laboratories maintain current ISO/IEC 17025 accreditation for the specific test methods used in our verification protocol.
All peptides are manufactured in facilities adhering to current Good Manufacturing Practice standards with full batch documentation.
Graduate students, post-docs, and PI-led labs conducting in-vitro and in-vivo peptide research. We provide the analytical documentation your IRB and publications require.
Physicians and clinical researchers exploring peptide therapies under appropriate regulatory frameworks. Our CoA packages support IND and clinical-stage documentation needs.
503A/503B pharmacies, analytical testing labs, and quality-focused compounders. We supply reference standards and bulk research material with full traceability.
All compounds sold by Vivere Peptides are designated strictly for in-vitro and laboratory research by qualified professionals. They are not intended for human or veterinary administration, clinical diagnosis, or therapeutic use. Vivere Peptides LLC does not operate as a pharmacy, compounding facility, or medical provider. Purchasers assume full responsibility for compliance with all applicable federal, state, and local regulations governing the acquisition and use of research compounds.
Vivere Peptides LLC is a Montana-registered limited liability company established in 2024. We operate as an independent research compound supplier with no affiliation to any pharmaceutical manufacturer, compounding pharmacy, or clinical provider.
Our operational model is intentionally lean: core analytical quality and product strategy are managed in-house, while manufacturing, testing, and fulfillment are executed through a vetted partner network. This structure allows us to maintain rigorous quality oversight without the capital overhead of vertically integrated manufacturing.
We maintain direct relationships with two ISO/IEC 17025 accredited testing laboratories, three cGMP-compliant peptide synthesis facilities, and a climate-controlled fulfillment center in Bozeman, Montana. Every partner in our supply chain is subject to annual qualification review.
Vivere Peptides HQ
Product Strategy · QA Oversight · Customer Relations
3 cGMP Facilities
2 ISO 17025 Labs
Bozeman, MT
Verified Compound + Full Analytical Dossier
Same-Day Shipping · Climate-Controlled · Tamper-Evident
Our founding team brings backgrounds in analytical chemistry, pharmaceutical quality assurance, and scientific e-commerce. We built Vivere because we saw a market that prioritized marketing over methodology — and researchers who deserved better.
Our support specialists hold degrees in biochemistry, molecular biology, and pharmacology. When you contact Vivere with a technical question, you reach someone who understands peptide chemistry, HPLC interpretation, and reconstitution protocols — not a call-center script.
No compound enters our catalog without completing the full 7-point analytical protocol. We reject lots that major competitors would ship. Our acceptance rate is approximately 94% — the other 6% is the difference between a vendor and a partner.
We publish full chromatograms, not summaries. We list acceptance criteria, not just results. We show you the methodology, not just the conclusion. If a result is borderline, we tell you — and we tell you what we did about it.
We will never imply that research compounds are approved therapies. We will never use patient testimonials, before-and-after imagery, or dosing protocols that suggest clinical use. Our marketing is accurate because our science is accurate.
Same-day fulfillment. Climate-controlled chain. Tamper-evident packaging. Lot-specific documentation in every box. We treat the last mile with the same rigor as the first assay.
Browse 80+ research compounds — every lot backed by our 7-point analytical verification protocol and dual-lab ISO/IEC 17025 documentation.
Your cart is empty.
Browse Products